Journal of the International AIDS Society

Papers
(The H4-Index of Journal of the International AIDS Society is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Understanding adaptive responses in PrEP service delivery in Belgian HIV clinics: a multiple case study using an implementation science framework116
Sustaining the HIV/AIDS response: PEPFAR's vision67
HIV Glasgow, 23–26 October 2022, Glasgow, UK / Virtual65
Systematic review and meta‐analysis of retention and disengagement after initiation on antiretroviral therapy in low‐ and middle‐income countries after the introduction of Universal Test and Treat pol64
Effects of Stop‐Work orders on HIV testing, treatment and programmes for prevention of vertical transmission in four sub‐Saharan African countries62
“If they had a place to live, they would be taking medication”: a qualitative study identifying strategies for engaging street‐connected young people in the HIV prevention‐care continuum in Ken54
Population‐level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART)48
Exploring potential drug−drug interactions between masculinizing hormone therapy and oral pre‐exposure prophylaxis (F/TDF and F/TAF) among transgender men (iMACT study): a randomized, open‐label pharm48
Counselling behavioural interventions for HIV, STI and viral hepatitis among key populations: a systematic review of effectiveness, values and preferences, and cost studies44
When and how to intervene to improve the health of children born HIV‐free39
Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limit39
Do not forget the children: a model‐based analysis on the potential impact of COVID‐19‐associated interruptions in paediatric HIV prevention and care38
The effect of tracer contact on return to care among adult, “lost to follow‐up” patients living with HIV in Zambia: an instrumental variable analysis38
Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review36
Adherence challenges with daily oral pre‐exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study35
35
34
Leveraging HIV self‐testing to achieve the UNAIDS 2025 targets in the South and Southeast Asia region32
32
A cross‐sectional assessment of injection of “salts” and HIV transmission‐related behaviours among a cohort of people who inject drugs in Kyrgyzstan32
Community‐led monitoring: a voice for key populations in Zimbabwe32
Effectiveness of HIV self‐testing when offered within assisted partner services in Western Kenya (APS‐HIVST Study): a cluster randomized controlled trial31
Issue Information31
India's adaptation of HIV services to ensure continuity of service delivery during the COVID‐19 pandemic31
A cross‐sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV‐1 in tenofovir disoproxil fumarate‐based pre‐exposure prophylaxis rollout program30
Contents30
Experiences of oral pre‐exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study30
Issue Information30
Patterns of daily oral HIV PrEP adherence among people who inject drugs in Ukraine: an analysis of biomarkers30
0.07627010345459